Breaking News

Financial Report: BASi

By Kristin Brooks | February 13, 2014

Revenues up 7% in the quarter driven by Culex sales

BASi
 
1Q Revenues: $6.2 million (+7%)
 
1Q Loss: $662,000 (earnings were $256 million 1Q12)
 
Comments: Service revenue was up 5% to $4.9 million. Product revenue increased 15% to $1.3 million, primarily due to higher sales of Culex automated sampling systems. Results include the impact of a change in warrant liability of $961,000 and a payment of $1.2 million to the company’s line of credit.
 
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision